Skip to main content

NIH Reveals Plan to Fund Human-Animal Chimeras

The public gets to weigh in before the US government lifts its ban on such research.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

FLICKR, ENGINEERING AT CAMBRIDGEThe US National Institutes of Health (NIH) has outlined a proposal to lift a ban on funding human-animal chimera research—with conditions. “The policy proposes prohibiting the introduction of certain types of human cells into embryos of nonhuman primates, such as monkeys and chimps, at even earlier stages of development than what was currently prohibited,” NPR’s Shots reported today (August 4). Additionally, a committee would review certain experiments that involved, say, human brain tissue.

Last September, NIH placed a moratorium on research that incorporated human pluripotent stem cells into early-stage animal embryos. Earlier rules from the agency don’t allow for human stem cells to contribute to the germ line of animals.

According to a blog post from Carrie Wolinetz, the associate director for science policy at the NIH, a steering committee would decide whether to fund research in two areas: human stem cells incorporated into nonhuman embryos at particular stages of development, and human cells that contribute to animal brain function.

“NIH is seeking public comment on the proposed scope of the chimera research to be considered by the NIH steering committee,” Wolinetz wrote. She added that the agency is also looking to strengthen its ban on breeding animals ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation